Results 11 to 20 of about 881,201 (350)
Microcirculatory dysfunction in cardiogenic shock
Annals of Intensive Care, 2023 Cardiogenic shock is usually defined as primary cardiac dysfunction with low cardiac output leading to critical organ hypoperfusion, and tissue hypoxia, resulting in high mortality rate between 40% and 50% despite recent advances.
Hamid Merdji +5 more
doaj +2 more sources
A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
Clinical Medicine Insights: Cardiology, 2022 This is a focused review looking at the pharmacological support in cardiogenic shock. There are a plethora of data evaluating vasopressors and inotropes in septic shock, but the data are limited for cardiogenic shock.
Aditi Shankar +6 more
doaj +2 more sources
Mechanical circulatory support in cardiogenic shock
Journal of Intensive Care, 2023 Cardiogenic shock is a complex and diverse pathological condition characterized by reduced myocardial contractility. The goal of treatment of cardiogenic shock is to improve abnormal hemodynamics and maintain adequate tissue perfusion in organs.
Jun Nakata +5 more
doaj +2 more sources
Practical aspects of managing patients with cardiogenic shock
Российский кардиологический журнал, 2023 Cardiogenic shock is the leading cause of death among patients with acute coronary syndrome. This pathology is characterized by high rates of inhospital and annual mortality.
M. M. Novosadov +3 more
doaj +1 more source
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2023 Background Acute myocardial infarction complicated by cardiogenic shock (AMI‐CS) is associated with significant morbidity and mortality. Mechanical circulatory support (MCS) devices increase systemic blood pressure and end organ perfusion while reducing ...
M. Basir +32 more
semanticscholar +1 more source
State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2023 Cardiogenic shock is characterized by tissue hypoxia caused by circulatory failure arising from inadequate cardiac output. In addition to treating the pathologic process causing impaired cardiac function, prompt hemodynamic support is essential to reduce
J. Bloom, W. Chan, D. Kaye, D. Stub
semanticscholar +1 more source
ESC Heart Failure, 2021 Cardiogenic shock (CS) portends high morbidity and mortality in the contemporary era. Despite advances in temporary mechanical circulatory supports (MCS), their routine use in CS to improve outcomes has not been established.
Nima Moghaddam +4 more
doaj +1 more source
European Journal of Heart Failure, 2023 This study aimed to give contemporary insight into the use of Impella and venoarterial extracorporeal membrane oxygenation (VA‐ECMO) in acute myocardial infarction‐related cardiogenic shock (AMICS) and into associated outcomes, adverse events, and ...
M. Bogerd +11 more
semanticscholar +1 more source
Cardiogenic shock - novelty and emerging therapeutic concepts [PDF]
Българска кардиология, 2022 The cardiogenic shock is a state of low cardiac output, primarily due to cardiac dysfunction, which leads to severe organ hypoperfusion with tissue hypoxia and increased lactate levels. It presents a severe complication with a prevalence of around 15% of
I. Petrov, Z. Stankov, S. Vasilev
doaj +3 more sources
Use of mechanical circulatory support in patients with non‐ischaemic cardiogenic shock
European Journal of Heart Failure, 2023 Despite its high incidence and mortality risk, there is no evidence‐based treatment for non‐ischaemic cardiogenic shock (CS). The aim of this study was to evaluate the use of mechanical circulatory support (MCS) for non‐ischaemic CS treatment.
B. Schrage +42 more
semanticscholar +1 more source